People
Darius Lakdawalla, PhD
Chief Scientific Officer, USC Schaeffer Institute
Senior Scholar, USC Schaeffer Institute
University Professor of Pharmaceutical Economics and Public Policy
Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, USC Mann School
Professor, USC Price School of Public Policy
Biography
Darius Lakdawalla is a widely published, award-winning researcher and a leading authority on health economics and health policy. He is the University Professor of Pharmaceutical Economics and Public Policy and holds the Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the University of Southern California, where he sits on the faculties of the Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the Sol Price School of Public Policy. He is also the Chief Scientific Officer at USC’s Leonard D. Schaeffer Institute for Public Policy & Government Service, which develops evidence-based, non-partisan solutions for critical policy challenges, with a focus on health, economics, and social sciences. His research has focused primarily on the economics of risks to health, the value and determinants of medical innovation, the economics of health insurance markets, and the industrial organization of healthcare markets. His academic work has appeared in leading peer-reviewed journals of economics, health policy, and medicine. His work has also been featured by prominent popular press outlets, such as the Wall Street Journal, National Public Radio, Forbes, and the New York Times. Dr. Lakdawalla received the PhRMA Foundation Value Assessment Challenge Award, designed to encourage innovative approaches to defining and measuring value in health care, in 2019 (third place) and 2020 (first place). He is the co-author of the recent book, Valuing Health: The Generalized and Risk-Adjusted Cost-Effectiveness (GRACE) Model, published by Oxford University Press. Dr. Lakdawalla is also an elected member (2025) of the National Academy of Medicine.
Latest Research View All
In The News View All
Bloomberg
Lakdawalla explains why MFN could hold back new treatments in Europe
Featured Experts: Darius Lakdawalla
Los Angeles Times
USC Schaeffer scholars quoted on the rollout of TrumpRx
Featured Experts: Geoffrey Joyce, Darius Lakdawalla
Bloomberg
Lakdawalla argues for a drug pricing system aligned with American values
Featured Experts: Darius Lakdawalla
KFF
Lakdawalla discusses recent developments in drug pricing policy on KFF webinar
Featured Experts: Darius Lakdawalla
CNBC
Lakdawalla discusses how White House obesity deal will broaden access
Featured Experts: Darius Lakdawalla
Tradeoffs Podcast
Lakdawalla interviewed about the uncertain impacts of the White House’s recent drug pricing deals
Featured Experts: Darius Lakdawalla